Climate Change Data

Alkem Laboratories Limited

Climate Impact & Sustainability Data (2016-17, 2022-23, 2023-24)

Reporting Period: 2016-17

Environmental Metrics

Waste Generated:Waste water effluent (KL): 92,640.9; ETP Sludge (MT): 43.77; Process Waste (MT): 699.13

ESG Focus Areas

  • Community Investment
  • Employee Well-being
  • Quality and Compliance

Environmental Achievements

  • Installation of energy-efficient equipment (LED lights, VFDs, economizers) resulting in energy savings.
  • Replacement of boiler fuel with briquettes, reducing energy consumption.
  • Use of solar energy at Mandva API plant.

Social Achievements

  • Launched various employee engagement initiatives (Star Awards, Service Awards, Applaud Awards).
  • Provided 30,000+ person days of training in FY17.
  • Undertook various CSR initiatives (healthcare, education, vocational training, environment conservation).

Governance Achievements

  • Successful US FDA inspections at Daman, Baddi, and Ankleshwar facilities.
  • Implementation of a Whistle Blower Policy.
  • Establishment of an Internal Complaints Committee to address sexual harassment complaints.

Climate Goals & Targets

Environmental Challenges

  • Expansion of NLEM list leading to price cuts in India.
  • Temporary hardships due to demonetization.
  • Pricing pressure in the US market due to buyer consolidation.
  • Regulatory compliance risks, exchange rate volatility, and geopolitical risks for exports.
Mitigation Strategies
  • Outperformance of the market through volume growth, new product launches, and improved field force productivity.
  • Cost optimization measures and improved operating efficiencies.
  • Focus on key international markets and differentiated products.
  • Continued investment in R&D and accelerated ANDA filings.

Supply Chain Management

Responsible Procurement
  • Green procurement initiatives focusing on raw materials, packaging, and finished goods.
  • Use of organic/bio fuels (80% of inputs for utility).

Climate-Related Risks & Opportunities

Awards & Recognition

  • EY Entrepreneur of the Year Award (Samprada Singh and Basudeo N. Singh)
  • Emerging Pharma Leader of 2016 (Sandeep Singh)
  • CEO of the Year 2016 (Prabhat Agrawal)
  • Brand of the Year (Pan)
  • HR Tech Award for Best use of Technology in Human Resources
  • Emerging Dermatology Brand 2015 (Melbild)
  • Silver Award, New Introduction of the Year, Chronic Category (Melbild)
  • Brand of the Year (Clavam)

Reporting Period: 2022-23

Environmental Metrics

Renewable Energy Share:16.75%

ESG Focus Areas

  • Healthcare
  • Education
  • Environment
  • Sports
  • Rural Development

Environmental Achievements

  • Planted over 1 million trees
  • Installed solar street lights
  • Developed a door-to-door garbage collection system
  • 90.49% wastewater reused
  • 25.80% hazardous waste disposed of sustainably
  • 16.75% energy from renewable sources

Social Achievements

  • Impacted over 10 lakh lives across India
  • Positively impacted 3 lakh lives through early cancer detection, anaemia-free panchayats, and supporting surgeries
  • Provided scholarships and developed infrastructure for education
  • Supported sports personalities with ₹10 Million for training
  • Empowered rural women and youth through Project Saksham, Project Swavalamban, and Alkem Aatma Nirbhar Gram
  • Supported cochlear implants, spine surgeries, and cataract surgeries

Governance Achievements

  • 25% women’s representation on the board
  • Established a robust monitoring and evaluation mechanism for CSR programs

Climate Goals & Targets

Environmental Challenges

  • Limited accessibility and affordability of healthcare in India
  • High TB burden in India, particularly in Sikkim
  • High rate of anaemia among women and children
  • Limited infrastructure and recognition for lesser-known sports
Mitigation Strategies
  • Partnered with Tata Memorial Centre (TMC) to provide cancer care
  • Established mini cancer units and a home-based palliative care unit
  • Launched Alkem Anaemia Mukti Abhiyaan (AAMA)
  • Supported training programs for emerging sports talents
  • Developed health centers and mobile health units to improve healthcare access

Supply Chain Management

Climate-Related Risks & Opportunities

Awards & Recognition

  • 9th National CSR Times Award
  • CSR Excellence Award by Economic Times (India Pharma World Awards 2023)
  • CSR Excellence Award by Global Business School, Amity Pune

Reporting Period: 2023-24

Environmental Metrics

Total Carbon Emissions:Not disclosed
Scope 1 Emissions:Not disclosed
Scope 2 Emissions:Not disclosed
Scope 3 Emissions:Not disclosed
Renewable Energy Share:Not disclosed
Total Energy Consumption:Not disclosed
Water Consumption:683,686 KL
Waste Generated:4,189.0 MT
Carbon Intensity:Not disclosed

ESG Focus Areas

  • Environment, Health, and Safety (EHS)
  • Climate Change
  • GHG Emissions
  • Biodiversity
  • Energy Management
  • Waste Management
  • Water Management
  • Product Quality
  • Occupational Health & Safety
  • Human Resource Development
  • Sustainable Supply Chain
  • Human Rights
  • Community Engagement
  • R&D and Innovation
  • Data Privacy and cybersecurity
  • Clinical Trial Conduct
  • Pharmacovigilance
  • Environmental Compliance
  • Corporate Governance
  • Business Continuity
  • Resilient Business Performance
  • Sales and marketing practices
  • Combatting counterfeit medicines

Environmental Achievements

  • 10.2% reduction in total volume of water consumption
  • 11.5% reduction of total electricity consumption (from non-renewable source - Grid)
  • 4,189.0 MT Waste recycled
  • 53.48% NOx reduction
  • 32.94% SOx reduction

Social Achievements

  • Certified as a “Great Place to Work” for the fourth time
  • Featured in India’s Top 100 best companies to work for
  • Launched ‘Alkemites Assistance Program’ for employee well-being
  • Enhanced term life insurance coverage for employees
  • Launched impactful signature training programs
  • 11 lakh Lives benefited through CSR initiatives

Governance Achievements

  • Appointment of Dr. Vikas Gupta as Chief Executive Officer
  • Appointment of Mr. Nitin Agrawal as Chief Financial Officer
  • Creation of the Chief Executive Officer position
  • Strengthened leadership team

Climate Goals & Targets

Long-term Goals:
  • Not disclosed
Medium-term Goals:
  • Achieve water neutrality by FY 2029-30
  • Reduce Scope-1 and Scope-2 GHG emissions by 42% by FY’33
Short-term Goals:
  • Reduce water consumption by 10% by FY 2029-30
  • Reduce Scope 1 & 2 GHG emissions by 42% by FY 2032-33
  • Achieve zero waste to landfill at operating sites by FY 2025-26
  • Increase overall gender diversity to 5% by FY 2026-27
  • More than 75% sites certified with ISO 45001 by FY’26
  • Obtain ISO 27001 certification by FY’26

Environmental Challenges

  • Supply chain challenges in the US
  • Subdued growth in certain acute therapies in India
  • Stiff competition from multiple competitors
  • Inadequate control on internal processes impacting product quality
  • Adverse pricing regulations affecting essential products
  • Disruption in production or supply chain at Sikkim Facility
  • Non-compliance with regulatory requirements
  • Changes in science and technology impacting R&D costs
  • Redundancy in technology used, lack of proper technological support or lack of awareness of information security among employees
  • Lack of energy efficiency consciousness
  • Lack of water resources at key locations
  • Violation of human rights principles
  • Gaps in pharmaceutical supply chain
  • Non-compliances with environmental regulations
  • Unethical behaviour or corporate misconduct
  • Poor corporate governance practices
  • Disruption to normal business operations
  • Presence of counterfeit products in the market
Mitigation Strategies
  • Cost optimization initiatives
  • Investing in R&D to develop unique products
  • Strong adherence to CGMP guidelines
  • Investing significantly in R&D to develop molecules/drugs ahead of competition
  • Robust cost control measures
  • Setting up alternative in-house manufacturing facilities and using contract manufacturing
  • Compliance and integrity measures
  • Astute business planning
  • Regular VAPT and IT audits
  • Implementing Microsoft Active Directory
  • Specialized pharmaceutical courses
  • Multiple initiatives for energy management
  • Monitoring and reducing water consumption
  • Rainwater harvesting and effluent treatment plants
  • Well-structured Human Rights policy
  • Code of Ethics for stakeholders
  • Comprehensive business continuity measures
  • Integrating ESG risks into Enterprise Risk Management system
  • Anti-counterfeiting Security features

Supply Chain Management

Supplier Audits: 90% of new suppliers screened on ESG criteria by FY’25

Responsible Procurement
  • Code of Ethics for suppliers, vendors, and contractors
  • ESG screening criteria for new suppliers
  • Associate Membership with Pharmaceutical Supply Chain Initiative (PSCI)

Climate-Related Risks & Opportunities

Physical Risks
  • Adverse weather events causing business disruptions
Transition Risks
  • Regulatory changes impacting essential products
Opportunities
  • Increased demand for healthcare services due to climate change impacts

Reporting Standards

Frameworks Used: Null

Certifications: ISO 14001, ISO 45001, ISO 50001

Third-party Assurance: DNV Business Assurance India Pvt. Ltd.

UN Sustainable Development Goals

  • Not disclosed

Not disclosed

Sustainable Products & Innovation

  • Not disclosed

Awards & Recognition

  • Great Place to Work
  • India’s Best Companies to Work For - Top 100
  • EY Entrepreneur of the Year in Life Sciences
  • Hurun India Lifetime Achievement Award
  • APEX India Foundation CSR Excellence Award 2023